Skip to main content
Veterinary Medicines

Otoxolan ear drops, suspension for dogs

Authorised
  • Dexamethasone acetate
  • Clotrimazole
  • Marbofloxacin

Product identification

Medicine name:
Otoxolan ear drops, suspension for dogs
Otoxolan Ohrentropfen, Suspension für Hunde
Active substance:
  • Dexamethasone acetate
  • Clotrimazole
  • Marbofloxacin
Target species:
  • Dog
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Dexamethasone acetate
    1.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Clotrimazole
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Marbofloxacin
    3.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Ear drops, suspension
Withdrawal period by route of administration:
  • Auricular use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02CA06
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Tad Pharma GmbH
  • Krka d.d. Novo Mesto
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 837428
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0438/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Czechia
  • Denmark
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 8/03/2023
Download
German (PDF)
Published on: 17/02/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 30/03/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 17/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."